These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36394820)

  • 1. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
    Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
    Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.
    Mendizabal M; Ridruejo E; Piñero F; Anders M; Padilla M; Toro LG; Torre A; Montes P; Urzúa A; Gonzalez Ballerga E; Silveyra MD; Michelato D; Díaz J; Peralta M; Pages J; García SR; Gutierrez Lozano I; Macias Y; Cocozzella D; Chavez-Tapia N; Tagle M; Dominguez A; Varón A; Vera Pozo E; Higuera-de la Tijera F; Bustios C; Conte D; Escajadillo N; Gómez AJ; Tenorio L; Castillo Barradas M; Schinoni MI; Bessone F; Contreras F; Nazal L; Sanchez A; García M; Brutti J; Cabrera MC; Miranda-Zazueta G; Rojas G; Cattaneo M; Castro-Narro G; Rubinstein F; Silva MO
    Ann Hepatol; 2021; 25():100350. PubMed ID: 33864948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic.
    Fründt T; Kuballa L; Lütgehetman M; Nörz D; Arend H; Brehm TT; Schulze Zur Wiesch J; Horvatits T; Horvatits K; Huber S; Wege H; Kluwe J
    PLoS One; 2021; 16(12):e0258450. PubMed ID: 34941875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver volumetry in cirrhotic patients with or without hepatocellular carcinoma: Its correlation with Child-Pugh, model for end-stage liver diseases and indocyanine green dye test.
    Patidar Y; Mittal K; Patel RK; Thomas SS; Sarin SK
    Indian J Gastroenterol; 2024 Aug; 43(4):760-767. PubMed ID: 38349461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
    Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
    J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
    Muñoz-Martínez S; Sapena V; Forner A; Bruix J; Sanduzzi-Zamparelli M; Ríos J; Bouattour M; El-Kassas M; Leal CRG; Mocan T; Nault JC; Alves RCP; Reeves HL; da Fonseca L; García-Juárez I; Pinato DJ; Varela M; Alqahtani SA; Alvares-da-Silva MR; Bandi JC; Rimassa L; Lozano M; González Santiago JM; Tacke F; Sala M; Anders M; Lachenmayer A; Piñero F; França A; Guarino M; Elvevi A; Cabibbo G; Peck-Radosavljevic M; Rojas Á; Vergara M; Braconi C; Pascual S; Perelló C; Mello V; Rodríguez-Lope C; Acevedo J; Villani R; Hollande C; Vilgrain V; Tawheed A; Ferguson Theodoro C; Sparchez Z; Blaise L; Viera-Alves DE; Watson R; Carrilho FJ; Moctezuma-Velázquez C; D'Alessio A; Iavarone M; Reig M
    Liver Int; 2022 Aug; 42(8):1891-1901. PubMed ID: 35608939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.
    Teh SH; Christein J; Donohue J; Que F; Kendrick M; Farnell M; Cha S; Kamath P; Kim R; Nagorney DM
    J Gastrointest Surg; 2005 Dec; 9(9):1207-15; discussion 1215. PubMed ID: 16332475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection.
    Guler-Margaritis S; Mercan-Stanciu A; Toma L; Rusie D; Isac T; Dodot M; Zgura A; Bacalbasa N; Haineala B; Badiu DC; Serban D; Iliescu EL
    In Vivo; 2021; 35(6):3377-3383. PubMed ID: 34697172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Lee PC; Huang YH; Wu JC; Lin HC; Chiang JH; Lee SD
    J Clin Gastroenterol; 2006 Jul; 40(6):543-50. PubMed ID: 16825938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience.
    Shin J; Yu JH; Jin YJ; Chae MH; Yoon CH; Lee JW
    Medicine (Baltimore); 2019 Nov; 98(47):e18020. PubMed ID: 31764818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease.
    Mak LY; Chung MSH; Li X; Lai FTT; Wan EYF; Chui CSL; Cheng FWT; Chan EWY; Cheung CL; Au ICH; Xiong X; Seto WK; Yuen MF; Wong CKH; Wong ICK
    World J Hepatol; 2024 Feb; 16(2):211-228. PubMed ID: 38495273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
    Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
    van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
    J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.
    Cimsit C; Kursun M; Demircioglu O; Dilber F; Demirtas CO; Ergenc I
    Acad Radiol; 2023 Sep; 30 Suppl 1():S124-S131. PubMed ID: 37012127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B.
    Hwan YJ; Shin J; Jin YJ; Lee JW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):66-73. PubMed ID: 31268949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
    McDonald SA; Pollock KG; Barclay ST; Goldberg DJ; Bathgate A; Bramley P; Dillon JF; Fraser A; Innes HA; Kennedy N; Morris J; Went A; Hayes PC; Hutchinson SJ
    J Viral Hepat; 2020 Mar; 27(3):270-280. PubMed ID: 31696575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.
    Yatsuji S; Hashimoto E; Tobari M; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2009 Feb; 24(2):248-54. PubMed ID: 19032450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.